Form 8-K - Current report:
SEC Accession No. 0001641172-25-010112
Filing Date
2025-05-14
Accepted
2025-05-14 09:01:36
Documents
16
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44151
2 EX-99.1 ex99-1.htm EX-99.1 36718
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2393
  Complete submission text file 0001641172-25-010112.txt   311928

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE drma-20250514.xsd EX-101.SCH 3781
5 XBRL DEFINITION FILE drma-20250514_def.xml EX-101.DEF 26635
6 XBRL LABEL FILE drma-20250514_lab.xml EX-101.LAB 36718
7 XBRL PRESENTATION FILE drma-20250514_pre.xml EX-101.PRE 25259
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5893
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 25942979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)